Published in Medical Letter on the CDC and FDA, July 17th, 1995
A safe and effective vaccine against hepatitis B was introduced in 1981 but despite this, infection rates changed little in the following years. Among heterosexuals and intravenous drug users, the incidence of hepatitis B increased.
"The strategy for hepatitis B prevention has been to vaccinate all groups at high risk for infection, through 1992, however, 80 percent of those who received...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.